AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases after a single dose worldwide. The company is headquartered in Cambridge, Massachusetts.
Tuesday’s top analyst upgrades and downgrades included Campbell Soup, Exact Sciences, Exelixis, Pool, Spirit Airlines and ZTO Express.
Thursday's top analyst upgrades and downgrades included Airbnb, CrowdStrike, DoorDash, Ford, Intuit, Lumber Liquidators, Occidental Petroleum, T-Mobile, Twilio, Uber and UBS.
Friday's top analyst upgrades and downgrades included Alteryx, Booking, CarGurus, Datadog, FedEx, First Solar, Uber Technologies, Vonage, Yeti and Zillow.
